| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $5,603,823 ) |
| | 2026 | 2026 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01DK138635 | Identifying a novel player in skeletal muscle performance and metabolism | 000 | 3 | NIH | 3/31/2026 | $589,326 |
| | 2026 | 2026 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R33DA065209 | The Buprenorphine Prescribing Support Program for Rural Primary Care | 000 | 1 | NIH | 3/19/2026 | $982,736 |
| | 2026 | 2026 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R21HD122149 | Tele-coaching for caregivers of young children with motor delays in rural communities | 000 | 1 | NIH | 6/11/2026 | $424,952 |
| | 2026 | 2026 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R15AG098725 | Mechanisms of Activity-Dependent Tau Release: The Role of Tau Interacting Proteins | 000 | 1 | NIH | 1/21/2026 | $567,256 |
| | 2026 | 2026 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01AG059779 | Combining GHR antagonism with life extending compounds: a search for synergies | 000 | 9 | NIH | 4/3/2026 | $638,054 |
| | 2026 | 2026 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R33DA065209 | The Buprenorphine Prescribing Support Program for Rural Primary Care | 001 | 1 | NIH | 5/1/2026 | $0 |
| | 2026 | 2026 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01AG097530 | Mechanisms of Muscle Adaptations in Aging and Exercise | 000 | 1 | NIH | 3/20/2026 | $588,701 |
| | 2026 | 2026 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01AR081804 | Growth hormone regulating chondrocyte metabolism for osteoarthritis development | 000 | 4 | NIH | 7/3/2026 | $499,782 |
| | 2026 | 2026 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01AG078129 | Neural mechanisms of age-related weakness | 000 | 4 | NIH | 6/9/2026 | $604,912 |
| | 2026 | 2026 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R25DK122952 | Diabetes Institute Summer Interprofessional Research Experience (DISIRE) for Undergraduates | 000 | 4 | NIH | 2/11/2026 | $102,639 |
| | 2026 | 2026 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01DC021429 | Treating Complex Sentences in Children with DLD | 000 | 3 | NIH | 4/21/2026 | $605,545 |
| | 2026 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | G2846290 | Rural Communities Opioid Response Program ? Mental and Behavioral Health | 02 | 4 | HRSA | 12/29/2025 | $0 |
| | 2026 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | T03OH009841 | Ohio University Training Project Grant in Occupational Safety | 02 | 13 | CDC | 11/13/2025 | $0 |
| | 2026 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01AG067758 | Motoneuronal mechanisms underlying age-related muscle weakness | 000 | 5 | NIH | 1/16/2026 | $0 |
| | 2026 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R03NS137135 | Inhibiting Adrenomedullin signaling to prevent mammalian brain endothelial cell abnormalities and brain arteriovenous malformation | 000 | 2 | NIH | 5/25/2026 | $0 |
| | 2026 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R03AI188450 | Generation and characterization of a small RNA mutant library in Neisseria gonorrhea | 000 | 2 | NIH | 3/5/2026 | $0 |
| | 2026 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | T03OH009841 | Ohio University Training Project Grant in Occupational Safety | 03 | 13 | CDC | 1/7/2026 | $0 |
| | 2026 | 2024 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | C06OD037793 | New Vivarium to Expand Biomedical Research Capacity at Ohio University | 000 | 1 | NIH | 3/3/2026 | $0 |
| | 2026 | 2024 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | T03OH009841 | Ohio University Training Project Grant in Occupational Safety | 02 | 13 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R21HD108761 | A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model | 000 | 2 | NIH | 6/15/2026 | $0 |
| | 2026 | 2024 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | T03OH009841 | Ohio University Training Project Grant in Occupational Safety | 03 | 13 | CDC | 1/7/2026 | $0 |
| | 2026 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R21AG081962 | Developing helical peptide antagonists of the growth hormone receptor | 000 | 1 | NIH | 12/19/2025 | $0 |
| | 2026 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | T03OH009841 | Ohio University Training Project Grant in Occupational Safety | 03 | 13 | CDC | 1/7/2026 | $0 |
| | 2026 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | T03OH009841 | Ohio University Training Project Grant in Occupational Safety | 02 | 13 | CDC | 11/13/2025 | $0 |
| | 2026 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01ES030425 | Molecular mechanisms of cNOS-mediated NF-kappa B activation in regulation of ultraviolet B light-induced photocarcinogenic responses | 000 | 5 | NIH | 6/30/2026 | -$80 |
| | 2026 | 2023 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R21NS130256 | Activity-dependent release of human alpha-synuclein | 000 | 1 | NIH | 1/13/2026 | $0 |
| | 2026 | 2022 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R15MH128703 | Fear, gastrointestinal distress, and interoception: Physiological and psychological mechanisms in eating disorders | 000 | 1 | NIH | 2/13/2026 | $0 |
| | 2026 | 2021 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R15AG073922 | Mechanisms of Age-Related Impairments in Human Skeletal Muscle Glucose Metabolism | 000 | 1 | NIH | 6/28/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $5,883,811 ) (Continued on the next page) |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R15GM152962 | Synthetic Biology Approaches to Engineer Lactococcus lactis for Targeted Delivery of Therapeutic Lasso Peptides | 000 | 1 | NIH | 8/18/2025 | $460,166 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01AG059779 | Combining GHR antagonism with life extending compounds: a search for synergies | 001 | 8 | NIH | 4/18/2025 | $563,458 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01AG059779 | Combining GHR antagonism with life extending compounds: a search for synergies | 002 | 8 | NIH | 6/12/2025 | $50,083 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01DK138635 | Identifying a novel player in skeletal muscle performance and metabolism | 001 | 2 | NIH | 6/12/2025 | $58,930 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01DK138635 | Identifying a novel player in skeletal muscle performance and metabolism | 000 | 2 | NIH | 2/17/2025 | $530,396 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01AR081804 | Growth hormone regulating chondrocyte metabolism for osteoarthritis development | 000 | 3 | NIH | 7/15/2025 | $473,983 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01AG078129 | Neural mechanisms of age-related weakness | 000 | 3 | NIH | 7/25/2025 | $603,730 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01AG067758 | Motoneuronal mechanisms underlying age-related muscle weakness | 001 | 5 | NIH | 6/17/2025 | $45,073 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01AG067758 | Motoneuronal mechanisms underlying age-related muscle weakness | 000 | 5 | NIH | 3/11/2025 | $507,067 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R15GM110602 | Novel Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as Therapeutic Agents | 001 | 3 | NIH | 8/20/2025 | $566,250 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R25DK122952 | Diabetes Institute Summer Interprofessional Research Experience (DISIRE) for Undergraduates | 001 | 3 | NIH | 7/14/2025 | $10,450 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R25DK122952 | Diabetes Institute Summer Interprofessional Research Experience (DISIRE) for Undergraduates | 000 | 3 | NIH | 12/19/2024 | $94,046 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R03NS137135 | Inhibiting Adrenomedullin signaling to prevent mammalian brain endothelial cell abnormalities and brain arteriovenous malformation | 001 | 2 | NIH | 8/14/2025 | $24,078 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R03NS137135 | Inhibiting Adrenomedullin signaling to prevent mammalian brain endothelial cell abnormalities and brain arteriovenous malformation | 000 | 2 | NIH | 4/14/2025 | $75,500 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R03AI188450 | Generation and characterization of a small RNA mutant library in Neisseria gonorrhea | 000 | 2 | NIH | 8/25/2025 | $75,500 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | R01DC021429 | Treating Complex Sentences in Children with DLD | 000 | 2 | NIH | 4/25/2025 | $612,095 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | G2846290 | Rural Communities Opioid Response Program ? Mental and Behavioral Health | 00 | 4 | HRSA | 9/5/2025 | $500,000 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | T2639453 | Opioid-Impacted Family Support Program | 00 | 6 | HRSA | 8/13/2025 | $599,384 |
| | 2025 | 2025 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | T03OH009841 | Ohio University Training Project Grant in Occupational Safety | 01 | 13 | CDC | 8/4/2025 | $147,378 |
| | 2025 | 2024 | OHIO UNIVERSITY | 1 OHIO UNIVERSITY | ATHENS | OH | 45701-2979 | ATHENS | USA | T03OH009841 | Ohio University Training Project Grant in Occupational Safety | 01 | 13 | CDC | 8/4/2025 | $0 |
|
